Vantrela™ ER (hydrocodone bitartrate) – New Drug Approval
January 18, 2017 – Teva announced the FDA approval of Vantrela ER (hydrocodone bitartrate) extended-release (ER) tablets, for the management of pain severe enough to require daily, around-the-clock, long-term opioid treatment and for which alternative treatment options are inadequate.
Top